Dementia Alzheimers Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Dementia Alzheimers clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Cognitive ImpairmentDementiaCognitive Dysfunction+7 more
Mclean Hospital40 enrolled1 locationNCT05245903
Recruiting

Assessing Cognitive Decline at Home

DementiaDementia AlzheimersMild Cognitive Impairment+3 more
Stanford University25 enrolled1 locationNCT06704971
Recruiting

Persons With Dementia and Their Extended Family Caregivers

DementiaNeuro-Degenerative DiseaseDementia Alzheimers+2 more
Karen Roberto360 enrolled1 locationNCT04863859
Recruiting

HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging Population

DementiaDementia, VascularDementia, Mixed+3 more
Bitbrain500 enrolled1 locationNCT06993207
Recruiting

Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease

Dementia AlzheimersAlzheimer s DiseaseMCI Due to AD
Hanze University of Applied Sciences Groningen208 enrolled1 locationNCT06508268
Recruiting

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease

Dementia AlzheimersMild Cognitive ImpairmentNeurocognitive Disorders+1 more
University Hospital, Basel, Switzerland100 enrolled1 locationNCT03672279
Recruiting
Not Applicable

Blood-based Biomarkers for Diagnosis of Alzheimer's

Dementia Alzheimers
Helse Stavanger HF300 enrolled1 locationNCT05187819
Recruiting

The Dampness Syndrome of Chinese Medicine Cohort Study

CancerMetabolic DiseaseAging+3 more
Guangzhou University of Traditional Chinese Medicine100,000 enrolled1 locationNCT05315895
Recruiting

PUMCH Dementia Longitudinal Cohort Study

DementiaDementia, MildDementia, Vascular+4 more
Peking Union Medical College Hospital20,000 enrolled1 locationNCT05023564